Balversa
Ended Awarded Last action
- Contract number
- 36C24121F0125
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $45,272
Award facts
- Contract value 100% obligated
- $45,271.88 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Augusta, ME 04330, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$22,636 | |
| Other Administrative Action | -$22,636 | |
| Original award | $90,544 |
About this award
This federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., is for the delivery of BALVERSA (erdafitinib), a cancer treatment drug, to the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) with a ceiling value of $45,271.88 and a period of performance through January 31, 2022. This BPA was established in March 2021 under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), a larger $3.1 billion multiple-award vehicle. The contract does not have a set-aside designation, as Janssen Biotech is a large, for-profit pharmaceutical manufacturer. The contract supports the VA's Veterans Health Administration (VHA) in providing critical oncology medications to veterans across the country through its network of Veterans Integrated Service Networks (VISNs).
Quick answers
Who was awarded contract 36C24121F0125?
36C24121F0125 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on March 10, 2021.
How much is contract 36C24121F0125 worth?
The government has obligated $45,272 on 36C24121F0125.
Is contract 36C24121F0125 an order under another contract?
Yes. 36C24121F0125 is a BPA call under 36F79719D0217-36E79720A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24121F0125 competed?
The extent of competition for 36C24121F0125 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award